Craig Chatham

Craig Chatham has extensive finance and analysis experience spanning over two decades. Craig most recently served as the Vice President of Financial Planning and Analysis at EyePoint Pharmaceuticals since September 2021. Prior to that, they held the role of Finance Director and Head of Financial Planning and Analysis at Sumitomo Dainippon Pharma Oncology from June 2019 to September 2021. Craig also worked at Shire, where they held various finance leadership positions, including Director and Head of US Internal Medicine and Oncology Finance, Finance Director for Gastrointestinal & Internal Medicine Business Units, and Director of Finance for Global Technical Operations. Before joining Shire, Craig worked as an Associate Director of Global Strategic Account Finance at Covance, a Manager of Financial Planning and Analysis at Pharmasset, Inc., and a Senior Financial Auditor at Johnson & Johnson. Craig began their career as a Senior Research Associate in Analytical Chemistry at Pharmacopeia.

Craig Chatham obtained a Bachelor of Arts degree in Biology from Lehigh University in 1995. Craig then pursued further education and received an M.B.A. degree in Finance and Corporate Accounting from the University of Rochester - Simon Business School between 1998 and 2000.